Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.

MLA

Jauss, M., et al. “Imaging of Dopamine Receptors with [123I]Iodobenzamide Single-Photon Emission-Computed Tomography in Neuroleptic Malignant Syndrome.” Movement Disorders, vol. 11, no. 6, Nov. 1996, pp. 726–28. EBSCOhost, https://doi.org/10.1002/mds.870110621.

APA

Jauss, M., Krack, P., Franz, M., Klett, R., Bauer, R., Gallhofer, B., & Dorndorf, W. (1996). Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome. Movement Disorders, 11(6), 726–728. https://doi.org/10.1002/mds.870110621

Chicago

Jauss, M., P. Krack, M. Franz, R. Klett, R. Bauer, B. Gallhofer, and W. Dorndorf. 1996. “Imaging of Dopamine Receptors with [123I]Iodobenzamide Single-Photon Emission-Computed Tomography in Neuroleptic Malignant Syndrome.” Movement Disorders 11 (6): 726–28. doi:10.1002/mds.870110621.